These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

541 related items for PubMed ID: 2387341

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V, Ferguson KF, Heller G, Kernan NA.
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [Abstract] [Full Text] [Related]

  • 25. Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells.
    Bilgeri R, Petzer AL, Zilian U, Geisen FH, Schirmer M, Haun M, Konwalinka G.
    Exp Hematol; 1993 Mar; 21(3):432-7. PubMed ID: 8095026
    [Abstract] [Full Text] [Related]

  • 26. Mononuclear macrophage (M-CFC) colony formation in semisolid media in the absence of exogenous GM-CSF.
    Zinzar SN, Den T, Holland JF.
    J Cell Physiol; 1985 Sep; 124(3):457-66. PubMed ID: 3876346
    [Abstract] [Full Text] [Related]

  • 27. Response of human myeloid leukemia cells to various sources of colony-stimulating activity and phytohemagglutinin-conditioned medium.
    Taetle R, Caviles A, Koziol J.
    Cancer Res; 1983 May; 43(5):2350-7. PubMed ID: 6600965
    [Abstract] [Full Text] [Related]

  • 28. Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells.
    Roodman GD, Bird A, Hutzler D, Montgomery W.
    Exp Hematol; 1987 Oct; 15(9):928-35. PubMed ID: 2820776
    [Abstract] [Full Text] [Related]

  • 29. Effects of mast cell growth factor on Ara-C mediated acute myeloid leukemia cell killing.
    Tafuri A, De Felice L, Mascolo MG, Valentini T, Petrucci MT, Petti MC.
    Stem Cells; 1993 Jul; 11 Suppl 2():88-92. PubMed ID: 7691332
    [Abstract] [Full Text] [Related]

  • 30. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 31. Effects of recombinant interferons on the clonogenic growth of leukemic cells and normal hemopoietic progenitors.
    Hosoi T, Ozawa K, Urabe A, Takaku F.
    Int J Cell Cloning; 1985 Sep; 3(5):304-12. PubMed ID: 3930631
    [Abstract] [Full Text] [Related]

  • 32. Synergistic and antagonistic effects of recombinant human interleukin (IL) 3, IL-1 alpha, granulocyte and macrophage colony-stimulating factors (G-CSF and M-CSF) on the growth of GM-CSF-dependent leukemic cell lines.
    Santoli D, Yang YC, Clark SC, Kreider BL, Caracciolo D, Rovera G.
    J Immunol; 1987 Nov 15; 139(10):3348-54. PubMed ID: 3500218
    [Abstract] [Full Text] [Related]

  • 33. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C, Mangoni L, Almici C, Caramatti C, Rizzoli V.
    Stem Cells; 1993 Jul 15; 11 Suppl 2():170-4. PubMed ID: 7691323
    [Abstract] [Full Text] [Related]

  • 34. Role of suramin as an IL-1 inhibitor in suppression of acute myelogenous leukemia progenitor proliferation.
    Estrov Z, Talpaz M, Estey EH, Strassmann G.
    Exp Hematol; 1995 Sep 15; 23(10):1080-7. PubMed ID: 7544738
    [Abstract] [Full Text] [Related]

  • 35. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE, Cooper S, Williams DE, Hangoc G, Gutterman JU, Vadhan-Raj S.
    Exp Hematol; 1988 Aug 15; 16(7):594-602. PubMed ID: 3260558
    [Abstract] [Full Text] [Related]

  • 36. Preferential suppression of low molecular weight natural tumor suppressor of human fetal liver origin on the growth of leukemic cells in vitro.
    Pei XT, Wu CT.
    Exp Hematol; 1990 Sep 15; 18(8):927-31. PubMed ID: 2387343
    [Abstract] [Full Text] [Related]

  • 37. Impact of in vivo administration of interleukin 3 on proliferation, differentiation, and chemosensitivity of acute myeloid leukemia.
    Gore SD, Weng LJ, Jones RJ, Cowan K, Zilcha M, Piantadosi S, Burke PJ.
    Clin Cancer Res; 1995 Mar 15; 1(3):295-303. PubMed ID: 9815985
    [Abstract] [Full Text] [Related]

  • 38. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
    Broxmeyer HE, Williams DE, Lu L, Cooper S, Anderson SL, Beyer GS, Hoffman R, Rubin BY.
    J Immunol; 1986 Jun 15; 136(12):4487-95. PubMed ID: 3086433
    [Abstract] [Full Text] [Related]

  • 39. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
    McCrady CW, Li F, Pettit GR, Grant S.
    Exp Hematol; 1993 Jul 15; 21(7):893-900. PubMed ID: 7686503
    [Abstract] [Full Text] [Related]

  • 40. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation.
    Murohashi I, Endho K, Nishida S, Yoshida S, Jinnai I, Bessho M, Hirashima K.
    Exp Hematol; 1995 Aug 15; 23(9):970-7. PubMed ID: 7543418
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.